av/santhera-n--big.svg

COM:SANTHERA

Santhera Pharmaceuticals Switzerland

  • Stock

Last Close

7.90

22/11 16:30

Market Cap

85.47M

Beta: -

Volume Today

13.43K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
13.50K
-
1.72M
-
5.56M
223.07%
8.91M
60.32%
9.71M
9.01%
8.07M
16.92%
3.67M
54.53%
454.50K
87.62%
268K
41.03%
959.50K
258.02%
average payables
625.50K
-
1.13M
79.94%
2.47M
119.64%
3.43M
38.83%
3.58M
4.30%
5.39M
50.57%
7.01M
30.12%
5.32M
24.18%
3.11M
41.56%
3.15M
1.48%
4.76M
50.80%
average receivables
2.38M
-
4.48M
88.05%
4.83M
7.77%
2.73M
43.45%
1.62M
-
book value per share
19.16
-
36.65
91.23%
198.85
442.63%
118.52
40.40%
51.45
56.59%
40.38
21.51%
19.33
52.13%
-4.77
124.69%
0.39
108.14%
-0.72
284.49%
capex per share
-0.01
-
-0.44
3,979.56%
-0.96
119.03%
-0.60
37.98%
-2.23
272.75%
-31.40
1,309.40%
-0.21
99.34%
-0.03
87.74%
-0.00
82.81%
-0.06
1,379.10%
capex to depreciation
-0.01
-
-2.76
41,162.00%
-0.46
83.37%
-0.11
74.97%
-0.41
259.54%
-5.79
1,300.51%
-0.05
99.17%
-0.00
90.07%
-0.00
15.45%
-0.40
9,862.90%
-7.81
1,846.23%
capex to operating cash flow
0.00
-
0.03
5,854.28%
0.02
32.63%
0.01
39.92%
0.04
155.08%
0.57
1,521.51%
-0.09
115.44%
0.00
100.89%
0.00
48.62%
0.13
32,915.49%
-0.50
476.10%
capex to revenue
-0.00
-
-0.08
2,534.44%
-0.12
49.18%
-0.02
83.47%
-0.06
209.05%
-0.68
1,022.75%
-0.00
99.56%
-0.00
25.43%
0.01
515.12%
-0.53
5,728.99%
-0.23
56.61%
cash per share
13.60
-
37.06
172.49%
143.85
288.10%
79.41
44.80%
92.84
16.91%
31.88
65.66%
28.53
10.51%
9.32
67.33%
6.21
33.41%
0.02
99.64%
days of inventory on hand
916.09
-
721.54
21.24%
902.45
25.07%
720.53
20.16%
459.36
36.25%
16.83
96.34%
41.47
146.39%
10.97
73.54%
170.80
1,456.40%
days payables outstanding
1.56K
-
3.03K
94.91%
875.89
71.13%
335.95
61.64%
318.84
5.09%
558.45
75.15%
457.56
18.07%
133.07
70.92%
233.71
75.62%
395.79
69.35%
529.67
33.83%
days sales outstanding
91.34
-
66.72
26.95%
62.94
5.67%
7.61
-
debt to assets
0.48
-
0.49
2.27%
0.52
5.40%
0.80
53.88%
0.47
41.22%
0.70
47.84%
0.23
67.26%
debt to equity
1.65
-
1.96
19.09%
2.82
44.00%
-11.20
496.66%
32.36
388.94%
-1.02
103.14%
0.41
140.69%
dividend yield
0.72
-
earnings yield
-0.42
-
-0.02
95.49%
0.01
165.91%
-0.11
958.11%
-0.23
114.64%
-1.19
420.28%
-0.15
87.20%
-1.81
1,092.15%
-1.22
32.67%
-0.08
93.08%
enterprise value
8.75M
-
382.64M
4,272.67%
402.42M
5.17%
282.68M
29.75%
233.32M
17.46%
78.15M
66.50%
153.28M
96.13%
96.04M
37.34%
67.21M
30.01%
883.88M
1,215.03%
-5.31M
100.60%
enterprise value over ebitda
-1.70
-
-51.36
2,917.43%
-17.47
65.99%
-9.45
45.91%
-5.01
47.00%
-1.62
67.63%
-21.50
1,226.53%
-1.78
91.72%
-1.55
12.70%
-20.80
1,237.71%
-0.10
99.52%
ev to operating cash flow
-1.25
-
-63.11
4,931.13%
-17.97
71.52%
-10.42
42.04%
-5.89
43.49%
-2.06
64.94%
59.07
2,961.85%
-2.21
103.74%
-1.80
18.49%
-29.62
1,546.22%
-0.11
99.62%
ev to sales
6.63
-
147.68
2,125.99%
93.13
36.94%
14.85
84.05%
10.17
31.53%
2.47
75.72%
2.03
17.63%
6.40
214.69%
-42.14
758.52%
118.28
380.67%
-0.05
100.04%
free cash flow per share
-18.82
-
-13.33
29.19%
-42.87
221.62%
-43.85
2.30%
-65.44
49.22%
-86.35
31.95%
2.15
102.49%
-32.70
1,619.15%
-10.94
66.55%
-0.55
94.93%
free cash flow yield
-0.51
-
-0.02
96.90%
-0.05
204.94%
-0.08
73.14%
-0.18
119.99%
-1.31
617.63%
0.02
101.45%
-1.17
6,252.54%
-0.82
29.58%
-0.04
95.11%
graham net net
6.51
-
24.93
282.99%
126.66
408.02%
65.01
48.67%
-17.70
127.23%
-75.10
324.26%
-53.69
28.51%
-61.87
15.23%
-20.01
67.66%
-1.74
91.30%
graham number
81.80
-
114.92
40.48%
223.19
94.22%
387.99
73.84%
308.45
20.50%
267.28
13.35%
86.65
67.58%
73.86
14.76%
11.92
83.86%
4.34
63.61%
income quality
1.21
-
0.80
33.53%
-7.63
1,048.02%
0.82
110.71%
0.77
5.45%
0.70
9.05%
-0.14
120.07%
0.65
557.18%
0.68
5.85%
0.42
38.10%
0.87
105.70%
intangibles to total assets
0.43
-
0.18
57.85%
0.25
37.94%
0.29
15.89%
0.21
26.61%
0.56
159.68%
0.51
8.79%
0.76
50.12%
0.71
7.09%
0.93
31.05%
0
100%
interest coverage
-348.05
-
-1.07K
208.54%
288.45
126.86%
-2.21K
865.62%
-13.13
99.41%
-11.42
12.98%
-1.72
84.97%
-7.70
348.62%
-3.46
55.03%
-2.57
25.68%
1.51
158.77%
interest debt per share
0.06
-
0.01
73.72%
0.02
38.35%
0.02
16.14%
90.84
379,814.37%
85.71
5.64%
60.12
29.86%
58.62
2.49%
17.38
70.35%
1.06
93.90%
inventory turnover
0.40
-
0.51
26.96%
0.40
20.05%
0.51
25.25%
0.79
56.85%
21.69
2,629.26%
8.80
59.41%
33.26
277.89%
2.14
93.57%
invested capital
1.65
-
1.96
19.09%
2.82
44.00%
-11.20
496.66%
32.36
388.94%
-1.02
103.14%
0.41
140.69%
market cap
13.79M
-
400.08M
2,800.20%
479.27M
19.80%
332.49M
30.63%
225.40M
32.21%
45.55M
79.79%
124.64M
173.62%
37.28M
70.09%
45.45M
21.89%
840.80M
1,750.11%
net current asset value
2.76M
-
12.82M
365.14%
73.04M
469.55%
45.91M
37.14%
84K
99.82%
-39.38M
46,983.33%
-44.55M
13.12%
-77.32M
73.56%
-65.15M
15.74%
-104.35M
60.17%
-14.51M
86.10%
net debt to ebitda
0.98
-
2.34
138.53%
3.34
42.56%
1.67
50.09%
-0.17
110.20%
-0.68
297.96%
-4.02
494.14%
-1.09
72.88%
-0.50
53.79%
-1.01
101.34%
-0.10
90.22%
net income per share
-15.52
-
-16.02
3.20%
11.13
169.52%
-56.45
607.02%
-82.19
45.59%
-78.63
4.34%
-17.26
78.05%
-50.81
194.36%
-16.25
68.02%
-1.17
92.82%
operating cash flow per share
-18.81
-
-12.89
31.49%
-41.90
225.12%
-43.26
3.23%
-63.21
46.13%
-54.94
13.08%
2.36
104.30%
-32.68
1,484.00%
-10.93
66.54%
-0.49
95.52%
payables turnover
0.23
-
0.12
48.69%
0.42
246.36%
1.09
160.72%
1.14
5.37%
0.65
42.91%
0.80
22.05%
2.74
243.84%
1.56
43.06%
0.92
40.95%
0.69
25.28%
receivables turnover
4.00
-
5.47
36.90%
5.80
6.01%
47.97
-
research and ddevelopement to revenue
3.57
-
2.20
38.43%
2.42
10.06%
0.93
61.61%
1.16
24.66%
1.21
4.34%
0.55
54.70%
2.28
316.80%
-18.63
916.88%
4.09
121.93%
0.18
95.58%
return on tangible assets
-1.04
-
-0.40
61.52%
0.07
116.90%
-0.55
911.68%
-0.60
8.42%
-1.11
85.68%
-0.34
69.78%
-3.22
860.02%
-2.09
34.97%
-15.72
651.07%
0.50
103.18%
revenue per share
3.56
-
5.51
54.86%
8.09
46.82%
30.34
275.15%
36.59
20.61%
45.94
25.53%
68.58
49.29%
11.27
83.56%
-0.47
104.14%
0.12
126.28%
roe
-0.81
-
-0.44
46.03%
0.06
112.81%
-0.48
950.69%
-1.60
235.40%
-1.95
21.88%
-0.89
54.14%
10.65
1,292.45%
-41.81
492.66%
1.63
103.89%
0.91
44.31%
roic
-1.03
-
-0.44
57.56%
0.06
113.88%
-0.48
885.03%
-0.59
24.96%
-0.63
5.69%
-0.13
79.83%
-0.79
522.93%
-1.25
58.74%
-26.41
2,009.58%
0.59
102.24%
sales general and administrative to revenue
2.36
-
1.61
31.82%
1.91
18.72%
0.52
73.00%
0.63
21.97%
0.49
22.76%
0.25
47.56%
0.83
225.68%
-7.98
1,062.50%
1.95
124.43%
shareholders equity per share
19.16
-
36.65
91.23%
198.85
442.63%
118.52
40.40%
51.45
56.59%
40.38
21.51%
19.33
52.13%
-4.77
124.69%
0.39
108.14%
-0.72
284.49%
stock based compensation to revenue
0.22
-
0.29
33.24%
0.47
61.17%
0.25
47.88%
0.42
71.60%
0.23
44.44%
0.08
64.62%
0.20
143.21%
-1.73
957.69%
0.73
142.15%
tangible asset value
2.88M
-
13.04M
352.66%
76.69M
488.05%
47.80M
37.67%
8.70M
81.81%
-33.64M
486.82%
-37.23M
10.68%
-74.03M
98.83%
-63.27M
14.53%
-102.89M
62.63%
60.46M
158.76%
tangible book value per share
7.77
-
27.72
256.84%
143.53
417.72%
76.20
46.91%
13.87
81.80%
-48.81
451.92%
-33.87
30.60%
-55.59
64.12%
-18.52
66.69%
-1.69
90.88%
working capital
3.75M
-
15.50M
313.00%
77.00M
396.62%
52.09M
32.34%
64.36M
23.55%
23.37M
63.68%
25.29M
8.20%
-11.35M
144.86%
-8.14M
28.25%
-46.35M
469.33%
-9.14M
80.29%

All numbers in (except ratios and percentages)